Profile: Axcan Pharma US, Inc. is a specialty pharmaceutical company. We manufacture, market and distribute gastroenterology products & concentrate on therapeutic treatments. Our product viokase® is a pancreatic enzyme concentrate of porcine origin containing standardized lipase, protease, and amylase as well as other pancreatic enzymes. It is available in tablet and powder dosage forms for oral administration. It is indicated in the treatment of exocrine pancreatic insufficiency as associated with but not limited to cystic fibrosis, chronic pancreatitis, pancreatectomy, or obstruction of the pancreas ducts. Our product flutter® is a secretion removal device for hands-free CPT that effectively and efficiently removes harmful secretions from the airways of patients with mucus producing respiratory conditions. It is indicated for the conditions like atelectasis, bronchitis, bronchiectasis, cystic fibrosis, chronic obstructive pulmonary diseases (COPDs) such as asthma & other conditions producing retained secretions.

The company was founded in 1982, has revenues of USD 100-500 Million, has ~440 employees and is CE certified.